Johnson & Johnson Innovation - JJDC, Inc. - 15 Sep 2023 Form 4/A Insider Report for CVRx, Inc. (CVRX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4/A
Accepted by SEC
02 Feb 2024, 17:47:50 UTC
Original report date
18 Sep 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Johnson & Johnson Innovation - JJDC, Inc., By: /s/ Jill McManus, Assistant Treasurer

Key filing fact

Johnson & Johnson Innovation - JJDC, Inc. filed Form 4/A for CVRx, Inc. (CVRX) on 02 Feb 2024.

Key facts

  • This page summarizes Johnson & Johnson Innovation - JJDC, Inc.'s Form 4/A filing for CVRx, Inc. (CVRX).
  • 16 reported transactions and 16 derivative rows are listed below.
  • Accepted by SEC: 02 Feb 2024, 17:47.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CVRX transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares
-237
Change %
-100%
Price
Shares after
0
Date
15 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
237
Exercise price
$0.2370
Footnotes
F1, F2, F3
CVRX transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares
-158
Change %
-100%
Price
Shares after
0
Date
15 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
158
Exercise price
$0.2370
Footnotes
F1, F2, F3
CVRX transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares
-189
Change %
-100%
Price
Shares after
0
Date
15 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
189
Exercise price
$0.2370
Footnotes
F1, F2, F3
CVRX transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares
-165
Change %
-100%
Price
Shares after
0
Date
15 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
165
Exercise price
$0.2370
Footnotes
F1, F2, F3
CVRX transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares
-118
Change %
-100%
Price
Shares after
0
Date
15 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
118
Exercise price
$0.2370
Footnotes
F1, F2, F3
CVRX transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares
-71
Change %
-100%
Price
Shares after
0
Date
15 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
71
Exercise price
$0.2370
Footnotes
F1, F2, F3
CVRX transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares
-23
Change %
-100%
Price
Shares after
0
Date
15 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
23
Exercise price
$0.2370
Footnotes
F1, F2, F3
CVRX transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares
-85
Change %
-100%
Price
Shares after
0
Date
15 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
85
Exercise price
$0.2370
Footnotes
F1, F2, F3
CVRX transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares
-758
Change %
-100%
Price
Shares after
0
Date
15 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
758
Exercise price
$0.2370
Footnotes
F1, F2, F3
CVRX transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares
-489
Change %
-100%
Price
Shares after
0
Date
15 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
489
Exercise price
$0.2370
Footnotes
F1, F2, F3
CVRX transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares
-758
Change %
-100%
Price
Shares after
0
Date
15 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
758
Exercise price
$0.2370
Footnotes
F1, F2, F3
CVRX transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares
-300
Change %
-100%
Price
Shares after
0
Date
15 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
300
Exercise price
$0.2370
Footnotes
F1, F2, F3
CVRX transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares
-758
Change %
-100%
Price
Shares after
0
Date
15 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
758
Exercise price
$1.19
Footnotes
F1, F2, F3
CVRX transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares
-142
Change %
-100%
Price
Shares after
0
Date
15 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
142
Exercise price
$1.19
Footnotes
F1, F2, F3
CVRX transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares
-758
Change %
-100%
Price
Shares after
0
Date
15 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
758
Exercise price
$3.96
Footnotes
F1, F2, F4
CVRX transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares
-1,264
Change %
-100%
Price
Shares after
0
Date
15 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,264
Exercise price
$5.14
Footnotes
F1, F2, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Johnson & Johnson Innovation - JJDC, Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 5 footnotes

Footnote F1

This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law,

Footnote F2

(Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein.

Footnote F3

Fully vested.

Footnote F4

Vests as to 1/48th of the shares each month commencing January 6, 2020.

Footnote F5

Vests as to 1/48th of the shares each month commencing January 11, 2021.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .